Sort
51,593 grants matching “hepatitis”
Identification of Candidate Gene Polymorphisms Associated with Infectious Diseas
$809,391Cheryl Ann Winkler · Basic Sciences · Z01 · FY2007 · CA
Dietary treatment of Glucose Transporter Type 1 Deficiency (G1D)
$809,360Juan M. Pascual · Ut Southwestern Medical Center · R01 · FY2019 · NS
HIV AND HEPATITIS IN YOUNG INJECTORS: A COMMUNITY STUDY
$809,338University Of California San Francisco · R01 · FY2000 · DA
Longitudinal integration of environmental exposures, omics, and childhood NAFLD (LEON) Study
$809,080Vaia Lida Chatzi · University Of Southern California · U01 · FY2024 · HG
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
$808,590Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2014 · AA
Genetic Epidemiology of Complex Traits
$808,519Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2014 · HG
Apolipoprotein C3-loading of apolipoprotein B100 lipoproteins and cardiovascular disease in patients with type 1 diabetes
$808,164Jay W Heinecke · University Of Washington · R01 · FY2025 · HL
HBV Prevention for Homeless At-Risk for HBV/HCV/HIV
$808,117University Of California Los Angeles · R01 · FY2005 · DA
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
$808,114Takara Leah Stanley · Massachusetts General Hospital · R01 · FY2019 · DK
Drug Metabolizing Enzymes In Humans
$807,999Joyce Goldstein · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES
Longitudinal integration of environmental exposures, omics, and childhood NAFLD (LEON) Study
$807,798Vaia Lida Chatzi · University Of Southern California · U01 · FY2023 · HG
Dietary treatment of Glucose Transporter Type 1 Deficiency (G1D)
$807,752Juan M. Pascual · Ut Southwestern Medical Center · R01 · FY2017 · NS
Biliary Atresia Consortium: Data Coordinating Center
$807,723John C Magee · University Of Michigan At Ann Arbor · U01 · FY2008 · DK
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
$807,629Takara Leah Stanley · Massachusetts General Hospital · R01 · FY2022 · DK
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
$807,629Takara Leah Stanley · Massachusetts General Hospital · R01 · FY2020 · DK
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
$807,629Takara Leah Stanley · Massachusetts General Hospital · R01 · FY2021 · DK
Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV
$807,482John C He · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · DK
Molecular signatures for liver cancer diagnosis and treatment stratification
$807,462Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
The role of cancer stem cells in liver cancer heterogeneity and subtypes
$807,462Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Core B - Developmental
$807,453Ira B Wilson · Miriam Hospital · P30 · FY2021 · AI
A smartphone-enabled point of care HCV Ag diagnostics to reduce HCV-related health disparities
$807,246Hadi Shafiee · Brigham And Women'S Hospital · R01 · FY2023 · EB
Clinical Research on Nonalcoholic Fatty Liver Disease
$807,150Joel Edward Lavine · Columbia University Health Sciences · U01 · FY2013 · DK
Center for the Study of Innate Immunity to HCV Infection
$807,007Michael J Gale · University Of Washington · U19 · FY2013 · AI
A systems immunology approach for predicting poor responses to Hepatitis B vaccination
$806,881Ramin Herati · New York University School Of Medicine · R01 · FY2024 · AI
General Clinical Research Center
$806,732Sheldon M Retchin · Virginia Commonwealth University · M01 · FY2010 · RR